Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000277.2(PAH):c.832A>G (p.Thr278Ala)

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA229801

102861 (ClinVar)

Gene: PAH

Condition: phenylketonuria

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: 67fbae05-2747-47fb-8f90-eb6e3ece3108

Approved on: 2020-06-11

Published on: 2021-09-24

HGVS expressions

NM_000277.2:c.832A>G

NM_000277.2(PAH):c.832A>G (p.Thr278Ala)

ENST00000553106.6:c.832A>G

ENST00000307000.7:c.817A>G

ENST00000549247.6:n.591A>G

ENST00000553106.5:c.832A>G

NM_000277.1:c.832A>G

NM_001354304.1:c.832A>G

NM_000277.3:c.832A>G

NM_001354304.2:c.832A>G

NC_000012.12:g.102852825T>C

CM000674.2:g.102852825T>C

NC_000012.11:g.103246603T>C

CM000674.1:g.103246603T>C

NC_000012.10:g.101770733T>C

NG_008690.1:g.69778A>G

NG_008690.2:g.110586A>G

Likely Pathogenic

PP4_Moderate PM3_Supporting PP3 PM2 PM5

Evidence Links 1

Expert Panel

Phenylketonuria VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Phenylketonuria VCEP

The c.832A>G (p.Thr278Ala) variant in PAH has been reported in multiple individuals with PKU and MHP (BH4 deficiency excluded). (PMID: 26503515, 30050108). This variant is absent in population databases. This variant was detected in the homozygous state in 1 patient (confirmed by parental testing). Computational evidence supports a deleterious effect. Another variant at this same amino acid is interpreted as pathogenic (p.Thr278Ile). In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PP4_Moderate, PM2, PM5, PM3_supporting PP3.

PP4_Moderate

Seen in 4 individuals with PKU. Biochemical testing data, including plasma phenylalanine (Phe) levels, dihydropteridine reductase activity, urinary biopterin and neopterin ratio, and tetrahydrobiopterin loading, were collected. PMID: 26503515

PM3_Supporting

detected in homozygous state in 1 patient. validation tests on parents were performed using Sanger sequencing. 0.5 pts. PMID: 30050108

PP3

Predicted deleterious by Polyphen, MutationTaster, and SIFT.

PM2

Absent from controls in ExAC, 1000 genomes, or gnomAD.

PM5

T278I interpreted as pathogenic in ClinVar 2 submitters

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.